Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients

Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):33-6. doi: 10.1510/icvts.2009.201848. Epub 2009 Apr 1.

Abstract

We wanted to evaluate if brain natriuretic peptide (BNP) is cleared during continuous veno-venous hemofiltration (CVVH) sessions in children with congenital heart disease. A prospective observational single-center study was conducted in a post-cardiac surgery intensive care unit of the city children's hospital. Ten children requiring CVVH for acute kidney injury following cardiac surgery were enrolled. Seven of them were undergoing postoperative extracorporeal membrane oxygenation. BNP clearance was evaluated by the difference between pre-filter and post-filter BNP blood amount indexed to pre-filter BNP concentration. All CVVH treatments were performed with 0.6 m2 polyacrylonitrile filter, in predilution setting, at a dose of 80 ml/kg/h. Troponin I and myoglobin levels were also measured and CVVH clearances of these markers calculated for comparison with BNP. A significant decrease in post-filter compared with pre-filter levels of BNP was shown in all 10 cases (P<0.01). Median BNP clearance was 35.6 (29-39.3) ml/min. Troponin I and myoglobin levels did not show any significant drop between pre- and post-filter values (P>0.05) and their clearance was significantly lower than BNP (P: 0.0004). A daily analysis of BNP levels showed a significant decrease of its blood concentration. BNP levels were significantly reduced after three and four days from CVVH start (P<0.05). During 80 ml/kg/h CVVH, utilizing polyacrylonitrile membranes, BNP is efficiently cleared from blood in a small cohort of pediatric post-cardiosurgical patients. In this situation, BNP absolute blood levels may be unpredictable.

MeSH terms

  • Acrylic Resins
  • Biomarkers / blood
  • Cardiac Surgical Procedures / adverse effects*
  • Down-Regulation
  • Extracorporeal Membrane Oxygenation
  • Heart Defects, Congenital / blood
  • Heart Defects, Congenital / surgery*
  • Hemofiltration*
  • Humans
  • Infant
  • Infant, Newborn
  • Kidney Diseases / blood
  • Kidney Diseases / etiology
  • Kidney Diseases / therapy*
  • Membranes, Artificial
  • Myoglobin / blood
  • Natriuretic Peptide, Brain / blood*
  • Prospective Studies
  • Treatment Outcome
  • Troponin I / blood

Substances

  • Acrylic Resins
  • Biomarkers
  • Membranes, Artificial
  • Myoglobin
  • Troponin I
  • Natriuretic Peptide, Brain
  • polyacrylonitrile